Metastatic Colorectal Cancers Recruiting Phase 2 Trials for Leucovorin (DB00650)

Also known as: Colorectal cancer metastatic / Metastatic Colorectal Cancer

DBCOND0063579 (Metastatic Colorectal Cancers)Recruiting2 IdentifierTitlePurposeDrugs
NCT03388190METIMMOX: Colorectal Cancer METastasis - Shaping Anti-tumor IMMunity by OXaliplatinTreatment
NCT03751176Second-line FOLFIRI + Panitumumab in Subjects With Wild Type RAS Metastatic ColorectalTreatment
NCT03117972Chemotherapy Intensification in Patients With High Lactate Dehydrogenase Values and Soluble Syndecan1 LevelsTreatment
NCT03279289Study to Assess the Efficacy and Safety of Treatment With FOLFIRI-aflibercept Compared to Initial Treatment With FOLFIRI-aflibercept (for 6 Cycles) Followed by Maintenance With 5FU-aflibercept, in an Elderly Population With mCRC After Failure of an Oxaliplatin-based RegimenTreatment
NCT03880877Regorafenib Plus FOLFIRI With Irinotecan Dose Escalated in Patients With Previously Treated Metastatic Colorectal CancerTreatment
NCT02414009Study to Compare CAPTEM vs FOLFIRI as Second Line Treatment in Advanced, Colorectal Cancer PatientsTreatment
NCT02063529FOLFOXIRI With or Without Cetuximab as First-line Treatment of Patients With Non-resectable Liver - Only Metastatic Colorectal CancerTreatment
NCT02128425FOLFOXIRI Compared to FOLFOX in First Line Treatment of Metastatic Colorectal CancerTreatment